SCHEMBL7015140

SCHEMBL7015140

CC(=O)N(N1CCNCC1)N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 1/20 0.38
KMT2A Q03164 3/20 0.34
MAPT P10636 1/20 0.33
PKM P14618 1/20 0.33
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA9 Q16790 2/20 0.31
CA2 P00918 2/20 0.31
CYP1A1 P04798 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
MEN1 O00255 2/20 0.31
TP53 P04637 2/20 0.31
CHKA P35790 1/20 0.31
GAA P10253 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27921097 0.83 KDM4E (0.38) SMN1; SMN2HTTKMT2AMAPTPKM
SCHEMBL28199271 0.71 CA2 (0.38) KMT2ACA12CA1CA9CA2
SCHEMBL7742546 0.71 SMN1; SMN2 (0.72) SMN1; SMN2HTTKMT2AMAPTCA12
SCHEMBL29840697 0.69 HSD17B10 (0.41) SMN1; SMN2HTTKMT2AMAPTPKM
SCHEMBL9391092 0.69 CA2 (0.39) KMT2ACA12CA1CA9CA2
SCHEMBL18878939 0.68 CA2 (0.35) KMT2ACA12CA1CA9CA2
Morpholine SCHEMBL29136408 0.67 SMN1; SMN2 (0.72) SMN1; SMN2HTTKMT2AMAPTPKM
SCHEMBL10650643 0.66 CA12 (0.46) SMN1; SMN2HTTKMT2ACA12CA1
SCHEMBL388370 0.66 CA2 (0.61) SMN1; SMN2KMT2AMAPTCA12CA1
SCHEMBL28220177 0.65 SMN1; SMN2 (0.42) SMN1; SMN2HTTKMT2AMAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912570-B1 BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS GLAXO GROUP LTD (GB) 2003-09-10 EP disclosed
EP-1304110-A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors GLAXO GROUP LIMITED (GB) 2003-04-23 EP disclosed
US-6174889-B1 PROTEIN TYROSINE KINASE INHIBITORS RELATED TO BIOISOSTERES OF QUINOLINE AND QUINAZOLINE DERIVATIVES; ANTICARCINOGENIC AND -TUMOR AGENTS; PSORIASIS; RESTENOSIS; RHEUMATOID ARTHRITIS, AUTOIMMUNE DISEASE, ALLERGY, ASTHMA AND GRAFT REJECTION GLAXO WELLCOME INC. 2001-01-16 US disclosed